165 related articles for article (PubMed ID: 35115500)
1. DGKZ promotes TGFβ signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFβR2.
Zhao Y; Sun H; Li X; Liu Q; Liu Y; Hou Y; Jin W
Cell Death Dis; 2022 Feb; 13(2):105. PubMed ID: 35115500
[TBL] [Abstract][Full Text] [Related]
2. NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis.
Chen M; Zhao Y; Yang X; Zhao Y; Liu Q; Liu Y; Hou Y; Sun H; Jin W
Breast Cancer Res Treat; 2021 Jun; 187(2):349-362. PubMed ID: 33864166
[TBL] [Abstract][Full Text] [Related]
3. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest.
Liu K; Xue B; Bai G; Zhang W
Bioengineered; 2021 Dec; 12(1):1517-1529. PubMed ID: 33926342
[TBL] [Abstract][Full Text] [Related]
5. Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor.
Zheng KX; Yuan SL; Dong M; Zhang HL; Jiang XX; Yan CL; Ye RC; Zhou HQ; Chen L; Jiang R; Cheng ZY; Zhang Z; Wang Q; Jin WZ; Xie W
World J Gastroenterol; 2023 May; 29(20):3103-3118. PubMed ID: 37346154
[TBL] [Abstract][Full Text] [Related]
6. Betulinic acid enhances TGF-β signaling by altering TGF-β receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells.
Chen CL; Chen CY; Chen YP; Huang YB; Lin MW; Wu DC; Huang HT; Liu MY; Chang HW; Kao YC; Yang PH
J Biomed Sci; 2016 Feb; 23():30. PubMed ID: 26922801
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of diacylglycerol kinase zeta (DGKZ) induces apoptosis and G2/M phase arrest in human acute myeloid leukemia HL-60 cells through MAPK/survivin/caspase pathway.
Li H; Dong C; Tian Y; Li X; Wang B; Zhai D; Bai Y; Chao X
Pharmazie; 2019 Jul; 74(7):418-422. PubMed ID: 31288898
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma.
Chung CL; Wang SW; Sun WC; Shu CW; Kao YC; Shiao MS; Chen CL
Biochem Pharmacol; 2018 Aug; 154():39-53. PubMed ID: 29678520
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.
Zhang XL; Topley N; Ito T; Phillips A
J Biol Chem; 2005 Apr; 280(13):12239-45. PubMed ID: 15661740
[TBL] [Abstract][Full Text] [Related]
11. Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.
González-González A; Muñoz-Muela E; Marchal JA; Cara FE; Molina MP; Cruz-Lozano M; Jiménez G; Verma A; Ramírez A; Qian W; Chen W; Kozielski AJ; Elemento O; Martín-Salvago MD; Luque RJ; Rosa-Garrido C; Landeira D; Quintana-Romero M; Rosato RR; García MA; Ramirez-Tortosa CL; Kim H; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Lorente JA; Sánchez-Rovira P; Chang JC; Granados-Principal S
Clin Cancer Res; 2018 Nov; 24(22):5697-5709. PubMed ID: 30012564
[No Abstract] [Full Text] [Related]
12. The involvement of lipid raft pathway in suppression of TGFβ-mediated metastasis by tolfenamic acid in hepatocellular carcinoma cells.
Sun J; Tao R; Mao T; Feng Z; Guo Q; Zhang X
Toxicol Appl Pharmacol; 2019 Oct; 380():114696. PubMed ID: 31381904
[TBL] [Abstract][Full Text] [Related]
13. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
[TBL] [Abstract][Full Text] [Related]
14. SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Huang S; Hu X; Liu S; Wu J; Shao ZM; Jin W
Cancer Res; 2016 Feb; 76(4):952-64. PubMed ID: 26676758
[TBL] [Abstract][Full Text] [Related]
15. Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway.
Bai F; Wang C; Liu X; Hollern D; Liu S; Fan C; Liu C; Ren S; Herschkowitz JI; Zhu WG; Pei XH
Cell Death Dis; 2022 Mar; 13(3):195. PubMed ID: 35236825
[TBL] [Abstract][Full Text] [Related]
16. Focal Adhesion Kinase Promotes Hepatic Stellate Cell Activation by Regulating Plasma Membrane Localization of TGFβ Receptor 2.
Chen Y; Li Q; Tu K; Wang Y; Wang X; Liu D; Chen C; Liu D; Yang R; Qiu W; Kang N
Hepatol Commun; 2020 Feb; 4(2):268-283. PubMed ID: 32025610
[TBL] [Abstract][Full Text] [Related]
17. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
McLean S; Di Guglielmo GM
Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.
Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849
[TBL] [Abstract][Full Text] [Related]
20. Long non-‑coding RNA SNHG16 functions as a tumor activator by sponging miR‑373‑3p to regulate the TGF‑β‑R2/SMAD pathway in prostate cancer.
Weng W; Liu C; Li G; Ruan Q; Li H; Lin N; Chen G
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
